Clinical Trial Update: Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating how renal impairment affects safety, tolerability, and pharmacokinetics of an experimental drug in obesity; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Pfizer | Conditions: Obesity | Phase 1 | Status: COMPLETED